Infectious Disease Control Global News & Press Release Distribution

Infectious Disease Control

All
APAC

Ascentage Pharma Announces Preclinical Data Demonstrating Olverembatinib's Therapeutic Potential in Treating COVID-19 Published in EMBO Molecular Medicine

SUZHOU, China and ROCKVILLE, Md., May 18, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that a new preclinical study, conducted by the rese...

2022-05-18 22:06 2146

Yiling Pharmaceutical: Lianhua Qingwen Approved in Nigeria

SHIJIAZHUANG, China, May 12, 2022 /PRNewswire/ -- Yiling Pharmaceutical disclosed Wednesday that it had received the medicine approval document for Lianhua Qingwen Capsules from the National Agency for Food and Drug Administration and Control (NAFDAC),Nigeria. The Product Category is Herbal and ...

2022-05-12 22:43 2238

A novel universal antiviral drug introduced in Korea

- Hyundai Bioscience launches CP-COV03 Phase 2 clinical trials - "To be an innovative medicine like penicillin that led to victory in the bacterial war" - Significant changes to the 'vaccine-dependent' virus response system SEOUL, South Korea, May 12, 2022 /PRNewswire/ -- The birth of a universa...

2022-05-12 18:19 2839

G20 Urges World Bank to Ready FIF Establishment: Indrawati

JAKARTA, Indonesia, April 24, 2022 /PRNewswire/ -- G20 members have urged the World Bank to immediately prepare for the establishment of the Financial Intermediary Fund (FIF), Finance MinisterSri Mulyani Indrawati stated. Indonesian Finance Min...

2022-04-24 20:22 1995

G20 Urges World Bank to Ready FIF Establishment: Indrawati

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

SHANGHAI, April 14, 2022 /PRNewswire/ -- April 13, 2022, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "the Group"; Stock Code: 600196.SH, 02196.HK) announced that the Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) self-developed by Fosun Diagnostics Co....

2022-04-14 19:45 2063

Fosun Diagnostics Receives China NMPA Approval for Its Independently Developed Novel Coronavirus Antigen Detection Kit Amidst of The National Efforts in Pandemic Prevention and Control

Happiness Development Donated Anti-epidemic Materials to Minhang District, Shanghai

NANPING, China, April 13, 2022 /PRNewswire/ -- Happiness Development Group Limited ("HAPP" or the "Company"), (NASDAQ: HAPP) an emerging and diversified company engaging in the business of production and sale of nutraceutical and dietary supplements, providing e-commerce sales and marketing solu...

2022-04-13 20:00 1880

Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers

JAKARTA, April 4, 2022 /PRNewswire/ -- Assuming the presidency in the upcoming G20 summit,Indonesia has begun the Health Working Group (HWG) meeting series that took place on28-30 March 2022 in Yogyakarta, Indonesia. Indonesia's Ministry of H...

2022-04-04 23:35 1860

Indonesia's Ministry of Health Discussed a Universal Vaccine Passport and Verifier for International Travelers

CCTV+: Peng Liyuan addresses World Tuberculosis Day video conference

BEIJING, March 24, 2022 /PRNewswire/ -- Peng Liyuan, wife of Chinese President Xi Jinping and World Health Organization (WHO) goodwill ambassador for Tuberculosis (TB) and HIV/AIDS, addressed the World Tuberculosis Day video conference on Thursday. &amp;nbsp; Global tuberculosis control...

2022-03-25 11:04 1869

INDICAID COVID-19 Rapid Antigen At-Home Test Receives FDA Emergency Use Authorization (EUA) for Over-the-Counter (OTC), Asymptomatic, Non- Prescription Use

GARDEN GROVE, Calif., March 22, 2022 /PRNewswire/ -- PHASE Scientific International, LTD (PHASE Scientific), a high-growth biotech company founded by bioengineers fromUCLA, announces that its INDICAID® COVID-19 Rapid Antigen At-Home Test (INDICAID® OTC) recei...

2022-03-23 00:00 1666

Joint Fight Against COVID-19, Viva Biotech Contributes to the Production of the Oral COVID-19 Antiviral Medication and Virus Tests

SHANGHAI, March 18, 2022 /PRNewswire/ -- At present, COVID-19 is still in pandemic status around the world. The superposition of Delta and Omicron variants are rampant, resulting in the continuous enhancement of their transmission ability. Amid the repeated waves of COVID-19, in addition to COVI...

2022-03-18 17:47 1665

Road to G20 Presidency, Indonesia Will Employ the Health Bubble System during the Event

JAKARTA, Indonesia, March 14, 2022 /PRNewswire/ -- On track to host the G20 summit inBali on November 15-16, The Indonesia's Ministry of Health is set to implement a strict health protocol system as a precaution against COVID-19. The system will serve as a guideline for every in-person activity d...

2022-03-14 20:03 1857

Road to G20 Presidency, Indonesia Will Employ the Health Bubble System during the Event

China.org.cn: Hong Kong's fight against COVID-19: a test for "one country, two systems"

BEIJING, March 4, 2022 /PRNewswire/ -- A news report from China.org.cn on Hong Kong's COVID-19 pandemic situation: &amp;nbsp; Hong Kong has been taken aback by the 5th onset of the COVID-19 pandemic, and it's spreading fast.Hong Kong is a metropolis that runs under the "one country, two...

2022-03-04 22:00 3387

HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)

TOKYO, Feb. 15, 2022 /PRNewswire/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technolo...

2022-02-15 16:00 1276

New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine

Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution inNew Zealand GAITHERSBURG, Md., Feb. 4, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for ser...

2022-02-04 06:54 2308

"Don't forget leprosy" campaign gathers pace as World Leprosy Day approaches

TOKYO, Jan. 28, 2022 /PRNewswire/ -- Sasakawa Leprosy (Hansen's Disease) Initiative is collaborating with 32 organizations from 13 countries to promote the message "Don't forget leprosy" in the run-up to World Leprosy Day onJanuary 30. The international campaign includes awareness-raising events ...

2022-01-28 19:00 1604

Yum China Certified Top Employer China for Fourth Consecutive Year, Honoring the Company's Commitment to Employee Care and Sustainable Career Development

SHANGHAI, Jan. 20, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) announced that the Top Employers Institute has certified the Company as a Top Employer China for the fourth consecutive year, withYum China the only restaurant company named ...

2022-01-20 17:32 2199

Yum China Certified Top Employer China for Fourth Consecutive Year, Honoring the Company's Commitment to Employee Care and Sustainable Career Development

Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive approval for provisional registration inAustralia GAITHERSBURG, Md., Jan. 20, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for seri...

2022-01-20 07:29 1263

SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US

NEW YORK, Dec. 15, 2021 /PRNewswire/ -- COVID-19 vaccines have once again become a hot topic inthe United States as President Joe Biden pushes on with vaccination mandates in a bid to manage concerns around the Omicron variant ahead of the winter flu season. Despite vaccination ratesreaching 60%...

2021-12-15 22:00 1359

SQREEM's New AI-powered Study Examines Motivations Surrounding COVID-19 Vaccine Resistance in the US

Info-Tech Research Group Reveals 2022 Tech Trends

SYDNEY, Dec. 15, 2021 /PRNewswire/ -- Info-Tech Research Group, one of the fastest-growing information technology and research advisory firms in the world, has revealed its annual tech trend insights for the coming year. Info-Tech offers research, diagnostics, and workshops to systematically impr...

2021-12-15 06:00 2234

Info-Tech Research Group Reveals 2022 Tech Trends

Biotron Drug Effective Against COVID-19 In Animals

* BIT225 administered orally significantly reduced viral load in the lungs and blood of animals challenged with SARS-CoV-2. * BIT225 protected against severe disease, indicated by the significant prevention of body weight loss in animals treated with BIT225 compared to non-treated controls. ...

2021-11-25 19:00 1921

1 2 345 6 7 ... 13